APR 29, 2019 6:45 AM PDT

Towards an Understanding of, and Potential Treatment for Chemobrain

WRITTEN BY: Carmen Leitch

Chemobrain is a term for the mental problems or brain fog that is associated with chemotherapy treatment. While patients complained of problems for years, clinicians and researchers had trouble pinpointing and documenting the symptoms; in part because they vary from one patient to another. There may also be many different causes. Learn more about chemobrain from the video. 

Cancer patients and survivors can experience significant impacts on their quality of life that last for years because of these cognitive impairments; they may have memory lapses, trouble concentrating, or difficulty finishing sentences for example. These symptoms can sometimes continue after treatment ends, and patients may have a hard time returning to their normal lives. It would be helpful to clinicians to know who is at risk for these symptoms, but to do so, a reliable biomarker of chemobrain has to be established. Researchers have taken steps toward that goal.

"By identifying the clinically relevant factors which predispose patients to chemobrain, more appropriate interventions can be tailored accordingly to patients who are at a higher risk of developing cognitive impairment," explained Associate Professor Alexandre Chan of the Department of Pharmacy, National University of Singapore (NUS) Faculty of Science. Chan led a team of researchers in a search for potential biomarkers.

One such biomarker is dehydroepiandrosterone (DHEA) and its sulfated form (DHEAS), together the neurosteroids are sometimes called DHEA(S). The researchers identified them as chemobrain biomarkers, as reported in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

In this study, 81 early-stage breast cancer patients without previous chemotherapy exposure, but who were scheduled to receive it as a treatment, were recruited. Patients were asked to complete questionnaires, self-assessments of cognitive function in several areas, and a computerized neuropsychological test before, during and after treatment. 

The scientists found that if a patient had high plasma levels of DHEAS before their chemotherapy treatment, they were at lower risk of getting chemobrain that impacted mental acuity and verbal fluency, specifically.

"Our findings suggest that patients with higher prechemotherapy DHEAS levels had lower odds of developing self-perceived cognitive impairment. However, future studies are required to further investigate the effect of DHEA(S) on specific cognitive domains and to validate our findings in independent cohorts," said graduate student and first author of the report Toh Yi Long.

Mr. Toh Yi Long, Associate Professor Alexandre Chan and Assistant Professor Lau Aik Jiang are members of the team that found clinically relevant factors which predispose patients to chemobrain. / Credit: National University of Singapore

The researchers are continuing to pursue this work. They are interested in therapies for chemobrain, which may also help with other complications of cancer treatment. The overall aim is to improve the quality of life for recovering cancer patients.


Sources: AAAS/Eurekalert! via National University of Singapore, Pharmacotherapy

About the Author
  • Experienced research scientist and technical expert with authorships on 28 peer-reviewed publications, traveler to over 60 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
JAN 11, 2020
Cell & Molecular Biology
JAN 11, 2020
To Save Others, Bacteria Can Self-Destruct When Infected by a Virus
Scientists were studying viruses that infect and kill bacteria as a medicine for bacterial infections over a hundred years ago, and they are a focus of recent research as well....
JAN 28, 2020
Immunology
JAN 28, 2020
Infectious Parasite Manipulates the Immune System to Survive
Toxoplasma gondii suppresses the immune system of the hosts it infects – human or otherwise – just enough to survive, thrive, and move on to mo...
MAR 02, 2020
Cell & Molecular Biology
MAR 02, 2020
Pushing the Limits of Ribosomes
Researchers engineer mutant ribosomes that can create biopolymers that are not found in nature....
FEB 26, 2020
Neuroscience
FEB 26, 2020
Immunotherapy Could Be Used to Treat Traumatic Brain Injury
Video:  Further explaination of microglia and their various functions.  Traumatic Brain Injuries are physical injuries to the brain which cause i...
MAR 07, 2020
Drug Discovery & Development
MAR 07, 2020
Do Surgical Masks Really Prevent the Spread of COVID-19?
As COVID-19 has spread around the world, there has been a global run on surgical masks. This has led some governments, such as that in India, to ban the ex...
MAR 31, 2020
Microbiology
MAR 31, 2020
Researchers Suggest Repurposing Pancreatitis Drug to Treat COVID-19
As SARS-CoV-2 upends normalcy in the world, researchers are trying to find a treatment for the illness it causes....
Loading Comments...